Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Artivion Inc.
- Study ID
- NCT07089576
- Status
- Recruiting
Conditions
- Acute Aortic Dissection
- Aortic Arch Aneurysm
- Aortic Arch Dissection
- Chronic Aortic Dissection
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Arcevo™ LSA Hybrid Stent Graft System — DEVICEThe Arcevo LSA Hybrid Stent Graft System is an implantable aortic stent graft with LSA branch which is preloaded onto a delivery system and implanted during an open surgical procedure, or more specifically a total arch replacement procedure. The device is intended for use with a proximal surgical graft (not supplied). If additional coverage is needed, a protocol specified thoracic endovascular aortic repair (TEVAR) device may be used.
Study Details
The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.
Key Dates
- Start date
- Nov 4, 2025
- Status verified
- May 2026
- Primary completion
- Apr 30, 2028
- Completion
- Jul 31, 2032
Study Design
- Enrollment
- 132 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Arcevo LSAThe Primary study arm will consist of patients with an aortic aneurysm or chronic aortic dissection (n=117). The Secondary study arm will include patients with acute or subacute aortic dissections (n=15).
Primary Outcome Measure
Composite Rate of Patients Free From ≥1 Major Adverse Event [ Time Frame: 1 year post-index procedure of LSA stent graft implant ]
Central Contacts
- Erin M Adams, MSPH800-438-8285
Locations (19)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35205 | Kyle Eudailey, MD (PRINCIPAL_INVESTIGATOR) |
| University of Southern California | Los Angeles | California | 90033 | Fernando Fleischman, MD (PRINCIPAL_INVESTIGATOR) |
| University of Colorado Hospital | Aurora | Colorado | 80045 | T. Brett Reece, MD (PRINCIPAL_INVESTIGATOR) |
| MedStar Washington Health | Washington D.C. | District of Columbia | 20010 | Christian Shults, MD (PRINCIPAL_INVESTIGATOR) |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | Bradley Leshnower, MD (PRINCIPAL_INVESTIGATOR) |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | Christopher Malaisrie, MD (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | Mehrdad Ghoreishi, MD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan | Ann Arbor | Michigan | 48109 | Shinichi Fukuhara, MD (PRINCIPAL_INVESTIGATOR) |
| Columbia University Irving Medical Center/New York Presbyterian Hospital | New York | New York | 10032 | Hiroo Takayama, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Cornell Medical College (Presbyterian Weill) | New York | New York | 10065 | Christopher Lau, MD (PRINCIPAL_INVESTIGATOR) |
| Northwell Health | New York | New York | 10075 | Derek Brinster, MD (PRINCIPAL_INVESTIGATOR) |
| Montefiore Medical Center | The Bronx | New York | 10467 | Joseph DeRose, MD (PRINCIPAL_INVESTIGATOR) |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | Patrick Vargo, MD, FACS (PRINCIPAL_INVESTIGATOR) |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | Michael Halbreiner, MD (PRINCIPAL_INVESTIGATOR) |
| University of Texas - Austin | Austin | Texas | 78705 | George Arnaoutakis, MD (PRINCIPAL_INVESTIGATOR) |
| University of Texas, McGovern Medical Center | Houston | Texas | 77030 | Anthony Estrera, MD (PRINCIPAL_INVESTIGATOR) |
| Baylor Scott & White | Plano | Texas | 75093 | Bill Brinkman, MD (PRINCIPAL_INVESTIGATOR) |
| University of Washington / Harborview Medical Center | Seattle | Washington | 98105 | Chris Burke, MD (PRINCIPAL_INVESTIGATOR) |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Jorge Mascaro, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By research site
Related Studies
- Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic PathologiesRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent GraftRecruiting · Baylor College of Medicine · Rochester, Minnesota
- GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval StudyRecruiting · W.L.Gore & Associates · Gainesville, Florida
- Evaluation of Branch Endografts in the Treatment of Aortic AneurysmsRecruiting · Baptist Health South Florida · Boca Raton, Florida